股票代码：002734 股票简称：利民股份 公告编号：2025-059 利民控股集团股份有限公司关于 公司控股股东、实际控制人减持计划的预披露公告 公司控股股东、实际控制人李明保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 公司控股股东、实际控制人李明拟在本减持计划公告之日起 15 个交易日后 的 90 个自然日内以大宗交易及集中竞价方式减持公司股份不超过 13,104,920 股 （占扣减回购股份公司总股本的 3%），其中以大宗交易方式减持公司股份不超过公 司总股本的 2%，以集中竞价交易方式减持公司股份不超过公司总股本的 1%。 利民控股集团股份有限公司（以下简称"公司"）近日收到公司控股股东、实 际控制人李明的《关于计划减持公司股份的通知》，现将具体事项公告如下： 一、股东的基本情况 | | | 持股占公 | | 拟减持股份占 | | | --- | --- | --- | --- | --- | --- | | | 股东性 | 持股数量 | | 拟减持股份 | | | 股东名称 | | ...

特别提示： 公司控股股东、实际控制人李明拟在本减持计划公告之日起 15 个交易日后 的 90 个自然日内以大宗交易及集中竞价方式减持公司股份不超过 13,104,920 股 （占扣减回购股份公司总股本的 3%），其中以大宗交易方式减持公司股份不超过公 司总股本的 2%，以集中竞价交易方式减持公司股份不超过公司总股本的 1%。 利民控股集团股份有限公司（以下简称"公司"）近日收到公司控股股东、实 际控制人李明的《关于计划减持公司股份的通知》，现将具体事项公告如下： 一、股东的基本情况 股票代码：002734 股票简称：利民股份 公告编号：2025-059 利民控股集团股份有限公司关于 公司控股股东、实际控制人减持计划的预披露公告 公司控股股东、实际控制人李明保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 1、股东名称：李明 2、拟减持股东持有公司股份情况： | 股东名称 | 股东性 | 持股数量 | 持股占公 | | 拟减持股份 | 拟减持股份占 | | --- | --- | --- | --- | --- ...

Investment Rating - The report maintains an "Outperform" rating for the agricultural chemical industry [7][10]. Core Views - The agricultural chemical industry is expected to benefit from rising prices of potassium fertilizer and glyphosate, with supply constraints for the insecticide "Kangkuan" [2][5]. - The potassium fertilizer market is characterized by tight supply and demand, with a significant reliance on imports, which is projected to increase due to food security concerns [2][27]. - The phosphoric chemical sector is anticipated to maintain high price levels due to the scarcity of phosphate rock resources and increasing demand from new applications [3][51]. Summary by Sections Potassium Fertilizer - Global potassium fertilizer prices are expected to recover as demand increases, with China being the largest consumer and heavily reliant on imports [2][27]. - Domestic production of potassium chloride is projected to decrease slightly in 2024, while imports are expected to reach a historical high [27]. - The domestic potassium chloride price is forecasted to rise by approximately 100 yuan/ton in July due to increased port prices [2][45]. Phosphoric Chemicals - The price of phosphate rock is expected to remain high due to declining grades and increasing extraction costs, with a tight supply-demand balance [3][51]. - As of June 30, 2025, the market price for 30% grade phosphate rock in Hubei is 1,040 yuan/ton, while in Yunnan it is 970 yuan/ton, both stable compared to the previous month [3][51]. - The export policy for phosphoric fertilizers emphasizes domestic priority, with reduced export quotas expected to alleviate downward pressure in the domestic market [4]. Pesticides - The supply of "Kangkuan" has been unexpectedly restricted, leading to a potential price increase for the product [5]. - Glyphosate prices have risen by 1,300 yuan/ton in June, driven by increased demand from South America as planting areas for soybeans and corn expand [5][9]. - The report recommends focusing on leading companies in the glyphosate sector, such as "Xingfa Group," which has a significant production capacity [9]. Key Company Recommendations - The report recommends "Yaji International" for potassium fertilizer, projecting production of 2.8 million tons in 2025 and 4 million tons in 2026 [5][49]. - For phosphoric chemicals, "Yuntianhua" and "Xingfa Group" are highlighted as key players due to their rich phosphate reserves [6]. - In the pesticide sector, "Xingfa Group" is recommended for its leading position in glyphosate production [9].

Market Overview - The Shanghai Composite Index rose by 0.32% on July 4, with 13 out of the 28 sectors experiencing gains, led by the banking and media sectors, which increased by 1.84% and 0.91% respectively [1] - The sectors that saw the largest declines were beauty care and non-ferrous metals, with decreases of 1.87% and 1.60% respectively [1] - The basic chemical industry ranked third in terms of decline today [1] Capital Flow Analysis - The net outflow of capital from the two markets was 21.74 billion yuan, with 8 sectors experiencing net inflows [1] - The computer industry had the largest net inflow of capital, totaling 2.81 billion yuan, despite a slight decline of 0.05% in its stock price [1] - The banking sector also saw a net inflow of 758 million yuan, with a daily increase of 1.84% [1] Basic Chemical Industry Performance - The basic chemical industry fell by 1.22%, with a total net outflow of 2.174 billion yuan [2] - Out of 401 stocks in this sector, 41 stocks rose, and 354 stocks fell, with 4 stocks hitting the daily limit down [2] - The top three stocks with the highest net inflow in the basic chemical sector were Huafeng Super Fiber (1.62 billion yuan), Dongcai Technology (1.39 billion yuan), and Limin Co., Ltd. (1.24 billion yuan) [2] Basic Chemical Industry Capital Inflow and Outflow - The top stocks with capital inflow included: - Huafeng Super Fiber: +1.83%, 16.59% turnover, 161.85 million yuan inflow - Dongcai Technology: +10.01%, 11.12% turnover, 138.64 million yuan inflow - Limin Co., Ltd.: +5.83%, 22.57% turnover, 124.30 million yuan inflow [2][3] - The top stocks with capital outflow included: - Dazhongnan: +2.55%, 38.91% turnover, -195.83 million yuan outflow - Wanhua Chemical: -0.86%, 0.72% turnover, -137.99 million yuan outflow - Yanhai Co., Ltd.: -2.43%, 0.88% turnover, -98.39 million yuan outflow [3]

Core Insights - The report maintains a "recommended" rating for the agricultural chemical industry, highlighting the recovery potential in the pesticide market due to rising glyphosate prices [1][8] - Glyphosate prices have shown a significant recovery, with the raw material price reaching 24,800 CNY per ton as of July 1, 2025, an increase of 1,800 CNY per ton since early April [6][8] Industry Performance - The basic chemical industry has outperformed the CSI 300 index over various time frames, with a 1-month performance of 5.0%, 3-month performance of 3.2%, and a 12-month performance of 16.4% compared to the CSI 300's 2.7%, 1.5%, and 13.6% respectively [4] Investment Highlights - The glyphosate industry is experiencing inventory depletion and demand recovery, leading to a price rebound from its bottom. As of June 27, 2025, glyphosate industry inventory was 40,000 tons, down 43,000 tons since early April [6] - The global largest glyphosate producer, Bayer, faces potential bankruptcy due to ongoing lawsuits related to its glyphosate product "Roundup," which could benefit domestic competitors in the glyphosate market [7] Company Focus - Key companies in the glyphosate sector include: - Jiangshan Chemical, with a production capacity of 70,000 tons/year [9] - Xingfa Group, the leading domestic glyphosate producer with a capacity of 230,000 tons/year [9] - Xin'an Chemical, with a capacity of 80,000 tons/year [10] - Yangnong Chemical, a major player with a capacity of 30,000 tons/year [10] - Guoxin Co., with a capacity of 20,000 tons/year [10] - Hebang Bio, with a capacity of 50,000 tons/year [10] - Lier Chemical, with a capacity of 18,500 tons/year [10] - Limin Co., with a capacity of 5,000 tons of glyphosate and 2,000 tons of refined glyphosate [10] Earnings Forecast - The report provides earnings per share (EPS) estimates for key companies, indicating potential growth in profitability: - Jiangshan Chemical: EPS of 1.10 CNY in 2025E [11] - Xingfa Group: EPS of 1.85 CNY in 2025E [11] - Yangnong Chemical: EPS of 3.44 CNY in 2025E [11] - Guoxin Co.: EPS of 1.12 CNY in 2025E [11] - Lier Chemical: EPS of 0.53 CNY in 2025E [11] - Limin Co.: EPS of 1.05 CNY in 2025E [11]

| 股票代码：002734 | 股票简称：利民股份 | 公告编号：2025-058 | | --- | --- | --- | | 债券代码：128144 | 债券简称：利民转债 | | 利民控股集团股份有限公司 一、可转换公司债券上市发行概况 经中国证券监督管理委员会《关于核准利民控股集团股份有限公司公开发行可 转换公司债券的批复》（证监许可［2020］3390 号）的核准，公司向社会公开发行 面值总额为人民币 980,000,000.00 元的可转换公司债券，发行数量为 9,800,000 张， 每张面值为人民币 100 元，债券期限为 6 年。 经深交所深证上【2021】278 号文同意，公司 980,000,000.00 元可转换公司债 券于 2021 年 3 月 24 日起在深交所挂牌交易，债券简称"利民转债"，债券代码 "128144"。 关于 2025 年第二季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： | 证券代码：002734 | 证券简称：利民股份 | | --- | --- | | 债券代码：128 ...

股票代码：002734 股票简称：利民股份 公告编号：2025-057 利民控股集团股份有限公司 关于子公司为子公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 4、最高额保证：威远生化为威远药业与中国民生银行股份有限公司石家庄分 行签订的《综合授信合同》【编号：ZHHT25000088507号】提供3,000万元最高额 保证担保； 5、保证方式：连带责任保证； 6、保证范围：主债权本金及利息、罚息、复利、违约金、损害赔偿金，及实 现债权和担保权利的费用（包括但不限于诉讼费、执行费、保全费、律师费、公正 费等）和其他应付的费用； 7、保证期间：自本合同生效之日起至主合同项下债务履行期限届满之日起三 利民控股集团股份有限公司（以下简称"公司"）子公司河北威远生物化工股 份有限公司（以下简称"威远生化"）为河北威远药业有限公司（以下简称"威远 药业"）在中国民生银行股份有限公司石家庄分行申请的额度为人民币 3,000 万元 综合授信业务提供最高额保证担保。 二、担保进展情况 2025 年 6 月 26 日，威远生化与中国民生银行 ...

Group 1 - The company announced a profit distribution plan for its subsidiaries, with a total distributable profit of 396,281,162.99 yuan [1] - The profit distribution amounts for each subsidiary are as follows: 46,394,229.37 yuan for Limin Chemical, 82,609,610.24 yuan for Shuangji Chemical, and 300,000,000.00 yuan for Weiyuan Pharmaceutical [1] - The company holds 100% equity in Limin Chemical, 79.5064% in Shuangji Chemical, and 21.71% in Weiyuan Pharmaceutical, which will result in dividend income of 300,000,000.00 yuan, 9,540,768.00 yuan, and 4,342,000 yuan respectively [1] Group 2 - The profit distribution will increase the net profit of the company's parent financial statements but will not affect the consolidated financial statements for the current year [1] - The overall operating performance of the company for the current year will remain unchanged due to this profit distribution [1]

Summary of Key Points Group 1: Guarantee Overview - The company has agreed to provide a joint liability guarantee for its subsidiary, Hebei Weiyuan Biochemical Co., Ltd., for a total amount not exceeding RMB 680 million for the year 2025 [1] - The guarantee is effective from the date of approval at the company's 2024 annual general meeting until the relevant guarantee amount proposal is reviewed at the 2025 annual general meeting [1] Group 2: Guarantee Progress - The company has provided a maximum guarantee for all main contracts signed between Weiyuan Biochemical and Bank of Communications Co., Ltd. Hebei Branch from June 17, 2025, to June 17, 2026, with a maximum debt amount of RMB 52 million [2] Group 3: Board of Directors' Opinion - The board believes that the guarantee for Weiyuan Biochemical is necessary for the subsidiary's daily operations and long-term development, aligning with the company's overall interests and not harming the interests of the company or minority shareholders [2] Group 4: Total External Guarantees - As of now, the total external guarantees provided by the company and its subsidiaries amount to RMB 1,126.115 million, which is 40.69% of the latest audited net assets attributable to the parent company's shareholders [2] - The guarantees provided by the company's subsidiaries to each other total RMB 50.8439 million, accounting for 1.92% of the latest audited net assets attributable to the parent company's shareholders [2] - There are no overdue guarantees, litigation-related guarantees, or losses incurred due to guarantees resulting in judgments against the company [2]

记载、误导性陈述或重大遗漏。 利民控股集团股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日召开第 六届董事会第七次会议，审议通过了《关于子公司利润分配的议案》，具体情况如 下： 一、子公司利润分配方案概况 1、截至 2024 年 12 月 31 日，利民化学有限责任公司（以下简称"利民化学"） 可供股东分配的利润为 396,281,162.99 元。公司拟决定利民化学向股东分配利润 300,000,000.00 元，占可供分配利润的 75.70%，剩余未分配利润结转以后年度分 配。 2、截至 2024 年 12 月 31 日，河北双吉化工有限公司（以下简称"双吉化工"） 可供股东分配的利润为 46,394,229.37 元。公司拟决定双吉化工向股东分配利润 12,000,000.00 元，占可供分配利润的 25.87%，剩余未分配利润结转以后年度分配。 股票代码：002734 股票简称：利民股份 公告编号：2025-055 利民控股集团股份有限公司 关于子公司利润分配的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 特此公告。 3、截至 2024 年 12 月 31 ...